advertisement
Your Special Attention For IGR 7-2
Compliance and persistency in glaucoma follow-up treatment
G.F. SchwartzCurrent Opinions in Ophthalmology 2005; 16: 114-121
Abstract no. 314
"Our patients may not take prescribed medication in at least 25% of cases."
The Friedenwald lecture: Glaucoma - Macrocosm to microcosm
H. QuigleyInvestigative Ophthalmology and Visual Science 2005; 46: 2663-2670
No abstract in IGR
"Masterful review of various aspects of glaucoma."
Medical versus surgical interventions for open angle glaucoma
J. Burr, A. Azuara-Blanco and A. AvenellCochrane Database of Systematic Reviews 2005; 2: CD004399
Abstract no. 598
"Meta-analysis of medication versus surgery."
Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials
P.C. Maier, J. Funk, G. Schwarzer, G. Antes and Y.T. Falck-YtterBritish Medical Journal 2005; 16: 331-134
Abstract no. 599
"Meta-analyses are necessary."
The economic burden of glaucoma and ocular hypertension: Implications for patient management: A review
J.-F. Rouland, G. Berdeaux and A. LafumaDrugs and Aging 2005; 22: 315-321
Abstract no. 727
"The financial aspect of glaucoma: don't forget there is a price tag to everything."
Applying the recent clinical trials on primary open angle glaucoma: the developing world perspective
R. Thomas, R.S. Kumar, G. Chandrasekhar and R. ParikhJournal of Glaucoma 2005; 14: 324-327
Abstract no. 738
"In the developing world conclusions are not the same."
Screening for glaucoma: Recommendation statement
N. Calonge, J.D. Allan, A.O. Berg, P.S. Frame, J. Garcia, L. Gordis, K.D. Gregory, R. Harris, M.S. Johnson, J.D. Kien, C. Loveland-Cherry, V.A. Moyer, J.K. Ockene, D.B. Petitti, A.L. Siu, S.M. Teutsch and B.P. YawnAnnals of Family Medicine 2005; 3: 171-172
No abstract in IGR
"The latest official statements on screening."
The science and marketing of dietary supplements
F.W. FraunfelderAmerican Journal of Ophthalmology 2005; 140: 302-304
No abstract in IGR
"Dietary supplements, not only for glaucoma. This booming market operates often outside the rigorous control of evidence based medicine. The emphasis is on lack of data."
Morphological changes in glaucomatous eyes and the role of TGF-b2 for the pathogenesis of the disease
E. Lütjen-DrecollExpert Eye Research 22005; 81: 1-4
Abstract no. 386
"Growth factor and glaucoma."
Changes in aqueous humor dynamics with age and glaucoma
B.T. Gabelt and P.L. KaufmanProgress in Retinal and Eye Research 2005; 24: 612-637
Abstract no. 418
"Glaucoma: just early aging?"
Considerations of glaucoma in patients undergoing corneal refractive surgery
K.P. Bashford, G. Shafranov, S. Tauber and M.B. ShieldsSurvey of Ophthalmology 2005; 50: 245-251
Abstract no. 514
"The 'Nota Bene's' for refractive surgery in glaucoma patients."
Trabecular meshwork and uveoscleral outflow models
D.H. JohnsonJournal of Glaucoma 2005; 14: 308-310
Abstract no. 419
"Specialized models."
Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all?
M. SchwartzJournal of Glaucoma 2005; 14: 321-323
Abstract no. 602
"Is glaucoma a neurodegeneration? Models."
Neuroprotective properties of certain beta-adrenoceptor antagonists used for the treatment of glaucoma
N.N. Osborne, J.P. Wood and G. ChidlowJournal of Ocular Pharmacology and Therapeutics 2005; 21: 175-181
Abstract no. 641
"The unanswered question: np."
Retinal ganglion cells and supporting elements in culture
L.A. LevinJournal of Glaucoma 2005; 14: 305-307
Abstract no. 427
"What cultures tell us and what not."
Primate glaucoma models
C.A. Rasmussen and P.L. KaufmanJournal of Glaucoma 2005; 14: 311-314
Abstract no. 459
"Models close to the Homo Sapiens."
Elevated intraocular pressure and optic nerve injury models in the rat
J.C. MorrisonJournal of Glaucoma 2005; 14: 315-317
Abstract no. 458
"Why the enthusiasm about the rat model?"
Elevated intraocular pressure and transgenic applications in the mouse
J.D. Lindsey and R.N. WeinrebJournal of Glaucoma 2005; 14: 318-320
Abstract no. 456
"Of mice and men."
